APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Prothrombin Complex Market Outlook and Growth Opportunities 2026

26 December 2025196 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Human Prothrombin Complex market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Prothrombin Complex market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Prothrombin Complex market include Takeda, Meheco Xinxing Pharma, Hualan Biological, Octapharma, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Prothrombin Complex market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Prothrombin Complex and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Prothrombin Complex sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Prothrombin Complex market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Prothrombin Complex Segment by Company

Takeda

Meheco Xinxing Pharma

Hualan Biological

Octapharma

Grifols

CSL

Human Prothrombin Complex Segment by Type

1000 IU/Vial

500 IU/Vial

600 IU/Vial

Others

Human Prothrombin Complex Segment by Application

Hemophilia B

Vitamin K Deficiency

Others

Human Prothrombin Complex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Prothrombin Complex status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Prothrombin Complex market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Prothrombin Complex significant trends, drivers, influence factors in global and regions.

6. To analyze Human Prothrombin Complex competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Prothrombin Complex market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Prothrombin Complex industry.

Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Prothrombin Complex in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Prothrombin Complex Industry Trends Table 2. Human Prothrombin Complex Industry Drivers Table 3. Human Prothrombin Complex Industry Opportunities and Challenges Table 4. Human Prothrombin Complex Industry Restraints Table 5. Global Human Prothrombin Complex Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Prothrombin Complex Revenue Share by Company (2021-2026) Table 7. Global Human Prothrombin Complex Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Human Prothrombin Complex Sales Volume Share by Company (2021-2026) Table 9. Global Human Prothrombin Complex Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Human Prothrombin Complex Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Prothrombin Complex Key Company Manufacturing Base & Headquarters Table 12. Global Human Prothrombin Complex Company, Product Type & Application Table 13. Global Human Prothrombin Complex Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1000 IU/Vial Table 18. Significant Companies of 500 IU/Vial Table 19. Significant Companies of 600 IU/Vial Table 20. Significant Companies of Others Table 21. Global Human Prothrombin Complex Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Human Prothrombin Complex Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Human Prothrombin Complex Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Human Prothrombin Complex Sales Volume Share by Type (2021-2026) Table 25. Global Human Prothrombin Complex Sales Volume Share by Type (2027-2032) Table 26. Global Human Prothrombin Complex Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Human Prothrombin Complex Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Human Prothrombin Complex Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Human Prothrombin Complex Sales Value Share by Type (2021-2026) Table 30. Global Human Prothrombin Complex Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hemophilia B Table 32. Significant Companies of Vitamin K Deficiency Table 33. Significant Companies of Others Table 34. Global Human Prothrombin Complex Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Human Prothrombin Complex Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Human Prothrombin Complex Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Human Prothrombin Complex Sales Volume Share by Application (2021-2026) Table 38. Global Human Prothrombin Complex Sales Volume Share by Application (2027-2032) Table 39. Global Human Prothrombin Complex Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Human Prothrombin Complex Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Human Prothrombin Complex Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Human Prothrombin Complex Sales Value Share by Application (2021-2026) Table 43. Global Human Prothrombin Complex Sales Value Share by Application (2027-2032) Table 44. Global Human Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Human Prothrombin Complex Sales by Region (2021-2026) & (K Units) Table 46. Global Human Prothrombin Complex Sales Market Share by Region (2021-2026) Table 47. Global Human Prothrombin Complex Sales by Region (2027-2032) & (K Units) Table 48. Global Human Prothrombin Complex Sales Market Share by Region (2027-2032) Table 49. Global Human Prothrombin Complex Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Human Prothrombin Complex Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Human Prothrombin Complex Sales Value Share by Region (2021-2026) Table 52. Global Human Prothrombin Complex Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Human Prothrombin Complex Sales Value Share by Region (2027-2032) Table 54. Global Human Prothrombin Complex Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Human Prothrombin Complex Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Human Prothrombin Complex Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 59. Global Human Prothrombin Complex Sales Market Share by Country (2021-2026) Table 60. Global Human Prothrombin Complex Sales by Country (2027-2032) & (K Units) Table 61. Global Human Prothrombin Complex Sales Market Share by Country (2027-2032) Table 62. Global Human Prothrombin Complex Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Human Prothrombin Complex Sales Value Market Share by Country (2021-2026) Table 64. Global Human Prothrombin Complex Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Human Prothrombin Complex Sales Value Market Share by Country (2027-2032) Table 66. Takeda Company Information Table 67. Takeda Business Overview Table 68. Takeda Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Takeda Human Prothrombin Complex Product Portfolio Table 70. Takeda Recent Development Table 71. Meheco Xinxing Pharma Company Information Table 72. Meheco Xinxing Pharma Business Overview Table 73. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio Table 75. Meheco Xinxing Pharma Recent Development Table 76. Hualan Biological Company Information Table 77. Hualan Biological Business Overview Table 78. Hualan Biological Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hualan Biological Human Prothrombin Complex Product Portfolio Table 80. Hualan Biological Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Octapharma Human Prothrombin Complex Product Portfolio Table 85. Octapharma Recent Development Table 86. Grifols Company Information Table 87. Grifols Business Overview Table 88. Grifols Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Grifols Human Prothrombin Complex Product Portfolio Table 90. Grifols Recent Development Table 91. CSL Company Information Table 92. CSL Business Overview Table 93. CSL Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. CSL Human Prothrombin Complex Product Portfolio Table 95. CSL Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Human Prothrombin Complex Distributors List Table 99. Human Prothrombin Complex Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Human Prothrombin Complex Product Image Figure 2. Global Human Prothrombin Complex Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Prothrombin Complex Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Prothrombin Complex Sales (2021-2032) & (K Units) Figure 5. Global Human Prothrombin Complex Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Human Prothrombin Complex Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1000 IU/Vial Image Figure 10. 500 IU/Vial Image Figure 11. 600 IU/Vial Image Figure 12. Others Image Figure 13. Global Human Prothrombin Complex Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Human Prothrombin Complex Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Human Prothrombin Complex Sales Volume Share by Type (2021-2032) Figure 16. Global Human Prothrombin Complex Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Human Prothrombin Complex Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Human Prothrombin Complex Sales Value Share by Type (2021-2032) Figure 19. Hemophilia B Image Figure 20. Vitamin K Deficiency Image Figure 21. Others Image Figure 22. Global Human Prothrombin Complex Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Human Prothrombin Complex Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Human Prothrombin Complex Sales Volume Share by Application (2021-2032) Figure 25. Global Human Prothrombin Complex Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Human Prothrombin Complex Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Human Prothrombin Complex Sales Value Share by Application (2021-2032) Figure 28. Global Human Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Human Prothrombin Complex Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Human Prothrombin Complex Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Human Prothrombin Complex Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Human Prothrombin Complex Sales Value (2021-2032) & (US$ Million) Figure 33. North America Human Prothrombin Complex Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Human Prothrombin Complex Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Human Prothrombin Complex Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Human Prothrombin Complex Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Human Prothrombin Complex Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Human Prothrombin Complex Sales Value (2021-2032) & (US$ Million) Figure 39. South America Human Prothrombin Complex Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Human Prothrombin Complex Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Human Prothrombin Complex Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Human Prothrombin Complex Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Human Prothrombin Complex Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Human Prothrombin Complex Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 1000 IU/Vial
  • 500 IU/Vial
  • 600 IU/Vial
  • Others
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Others
Companies covered
  • Takeda
  • Meheco Xinxing Pharma
  • Hualan Biological
  • Octapharma
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Prothrombin Complex Sales Value (2021-2032)
  4. 1.2.2 Global Human Prothrombin Complex Sales Volume (2021-2032)
  5. 1.2.3 Global Human Prothrombin Complex Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Prothrombin Complex Market Dynamics
  1. 2.1 Human Prothrombin Complex Industry Trends
  2. 2.2 Human Prothrombin Complex Industry Drivers
  3. 2.3 Human Prothrombin Complex Industry Opportunities and Challenges
  4. 2.4 Human Prothrombin Complex Industry Restraints
3 Human Prothrombin Complex Market by Company
  1. 3.1 Global Human Prothrombin Complex Company Revenue Ranking in 2025
  2. 3.2 Global Human Prothrombin Complex Revenue by Company (2021-2026)
  3. 3.3 Global Human Prothrombin Complex Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Average Price by Company (2021-2026)
  5. 3.5 Global Human Prothrombin Complex Company Ranking (2024-2026)
  6. 3.6 Global Human Prothrombin Complex Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Prothrombin Complex Company Product Type and Application
  8. 3.8 Global Human Prothrombin Complex Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Prothrombin Complex Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Prothrombin Complex Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Prothrombin Complex Market by Type
  1. 4.1 Human Prothrombin Complex Type Introduction
  2. 4.1.1 1000 IU/Vial
  3. 4.1.2 500 IU/Vial
  4. 4.1.3 600 IU/Vial
  5. 4.1.4 Others
  6. 4.2 Global Human Prothrombin Complex Sales Volume by Type
  7. 4.2.1 Global Human Prothrombin Complex Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Human Prothrombin Complex Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Human Prothrombin Complex Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Human Prothrombin Complex Sales Value by Type
  11. 4.3.1 Global Human Prothrombin Complex Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Human Prothrombin Complex Sales Value by Type (2021-2032)
  13. 4.3.3 Global Human Prothrombin Complex Sales Value Share by Type (2021-2032)
5 Human Prothrombin Complex Market by Application
  1. 5.1 Human Prothrombin Complex Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Others
  5. 5.2 Global Human Prothrombin Complex Sales Volume by Application
  6. 5.2.1 Global Human Prothrombin Complex Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Prothrombin Complex Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Human Prothrombin Complex Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Human Prothrombin Complex Sales Value by Application
  10. 5.3.1 Global Human Prothrombin Complex Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Prothrombin Complex Sales Value by Application (2021-2032)
  12. 5.3.3 Global Human Prothrombin Complex Sales Value Share by Application (2021-2032)
6 Human Prothrombin Complex Regional Sales and Value Analysis
  1. 6.1 Global Human Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Prothrombin Complex Sales by Region (2021-2032)
  3. 6.2.1 Global Human Prothrombin Complex Sales by Region: 2021-2026
  4. 6.2.2 Global Human Prothrombin Complex Sales by Region (2027-2032)
  5. 6.3 Global Human Prothrombin Complex Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Prothrombin Complex Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Prothrombin Complex Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Prothrombin Complex Sales Value by Region (2027-2032)
  9. 6.5 Global Human Prothrombin Complex Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Prothrombin Complex Sales Value (2021-2032)
  12. 6.6.2 North America Human Prothrombin Complex Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Prothrombin Complex Sales Value (2021-2032)
  15. 6.7.2 Europe Human Prothrombin Complex Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Prothrombin Complex Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Prothrombin Complex Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Prothrombin Complex Sales Value (2021-2032)
  21. 6.9.2 South America Human Prothrombin Complex Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Prothrombin Complex Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Prothrombin Complex Sales Value Share by Country, 2025 VS 2032
7 Human Prothrombin Complex Country-level Sales and Value Analysis
  1. 7.1 Global Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Prothrombin Complex Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Prothrombin Complex Sales by Country (2021-2032)
  4. 7.3.1 Global Human Prothrombin Complex Sales by Country (2021-2026)
  5. 7.3.2 Global Human Prothrombin Complex Sales by Country (2027-2032)
  6. 7.4 Global Human Prothrombin Complex Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Prothrombin Complex Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Prothrombin Complex Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Prothrombin Complex Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Prothrombin Complex Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Prothrombin Complex Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Prothrombin Complex Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Prothrombin Complex Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Meheco Xinxing Pharma
  8. 8.2.1 Meheco Xinxing Pharma Company Information
  9. 8.2.2 Meheco Xinxing Pharma Business Overview
  10. 8.2.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
  12. 8.2.5 Meheco Xinxing Pharma Recent Developments
  13. 8.3 Hualan Biological
  14. 8.3.1 Hualan Biological Company Information
  15. 8.3.2 Hualan Biological Business Overview
  16. 8.3.3 Hualan Biological Human Prothrombin Complex Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hualan Biological Human Prothrombin Complex Product Portfolio
  18. 8.3.5 Hualan Biological Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Human Prothrombin Complex Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Human Prothrombin Complex Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Grifols
  26. 8.5.1 Grifols Company Information
  27. 8.5.2 Grifols Business Overview
  28. 8.5.3 Grifols Human Prothrombin Complex Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Grifols Human Prothrombin Complex Product Portfolio
  30. 8.5.5 Grifols Recent Developments
  31. 8.6 CSL
  32. 8.6.1 CSL Company Information
  33. 8.6.2 CSL Business Overview
  34. 8.6.3 CSL Human Prothrombin Complex Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CSL Human Prothrombin Complex Product Portfolio
  36. 8.6.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Prothrombin Complex Value Chain Analysis
  2. 9.1.1 Human Prothrombin Complex Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Prothrombin Complex Sales Mode & Process
  6. 9.2 Human Prothrombin Complex Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Prothrombin Complex Distributors
  9. 9.2.3 Human Prothrombin Complex Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst